KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Natera (NTRA) Research & Development (2016 - 2025)

Natera (NTRA) has disclosed Research & Development for 12 consecutive years, with $175.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Research & Development rose 35.33% year-over-year to $175.2 million, compared with a TTM value of $624.1 million through Dec 2025, up 54.43%, and an annual FY2025 reading of $624.1 million, up 54.43% over the prior year.
  • Research & Development was $175.2 million for Q4 2025 at Natera, up from $173.4 million in the prior quarter.
  • Across five years, Research & Development topped out at $175.2 million in Q4 2025 and bottomed at $40.2 million in Q1 2021.
  • Average Research & Development over 5 years is $96.5 million, with a median of $85.4 million recorded in 2022.
  • The sharpest move saw Research & Development skyrocketed 272.65% in 2021, then plummeted 33.46% in 2022.
  • Year by year, Research & Development stood at $71.8 million in 2021, then increased by 22.42% to $87.9 million in 2022, then decreased by 5.63% to $83.0 million in 2023, then skyrocketed by 56.04% to $129.5 million in 2024, then surged by 35.33% to $175.2 million in 2025.
  • Business Quant data shows Research & Development for NTRA at $175.2 million in Q4 2025, $173.4 million in Q3 2025, and $146.4 million in Q2 2025.